AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18430844 — intervention group
Group type: COMPARATOR
Intervention: Manual 3D measurement by observer 2
Number of subjects: 16
Study 18430844 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated measurement for phantom data
Number of subjects: 16
Study 18430844 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated measurement for patient data
Number of subjects: 16
Study 16485727 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) treatment (1200 mg/day in 3 divided doses for 3 days followed by 300 mg i.v. after anaesthesia induction)
Number of subjects: 25
Study 16485727 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline (PTX) treatment
Number of subjects: 25
Study 16485727 — intervention group
Group type: COMPARATOR
Intervention: Control group (no PTX treatment)
Number of subjects: 25
Study 14515290 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasonography (EUS)
Number of subjects: 100
Study 10866882 — intervention group
Group type: EXPERIMENTAL
Intervention: tranexamic acid, 10 mg. kg(‐1). h(‐1)
Number of subjects: 132
Study 10866882 — intervention group
Group type: EXPERIMENTAL
Intervention: epsilon‐aminocaproic acid, 16 mg. kg(‐1). h(‐1)
Number of subjects: 132
Study 10866882 — intervention group
Group type: COMPARATOR
Intervention: placebo (isotonic saline)
Number of subjects: 132
Study 9083732 — intervention group
Group type: EXPERIMENTAL
Intervention: New brochures
Number of subjects: 371
Study 9083732 — intervention group
Group type: COMPARATOR
Intervention: Old brochure
Number of subjects: 371
Study 8450440 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.2 mm incision
Number of subjects: 196
Study 8450440 — intervention group
Group type: COMPARATOR
Intervention: 5.0 mm incision
Number of subjects: 196
Study 8450440 — intervention group
Group type: COMPARATOR
Intervention: 6.0 mm incision
Number of subjects: 196
Study 8450440 — intervention group
Group type: COMPARATOR
Intervention: 5.0 mm and 6.0 mm incisions
Number of subjects: 196
Study 3092780 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam treatment in 8 patients
Number of subjects: 37
Study 3092780 — intervention group
Group type: COMPARATOR
Intervention: Rebreathing with CO2
Number of subjects: 37
Study 29663908 — intervention group
Group type: EXPERIMENTAL
Intervention: Glass carbomer cement
Number of subjects: 33
Study 29663908 — intervention group
Group type: COMPARATOR
Intervention: High-viscosity glass ionomer cement
Number of subjects: 33
Study 27161539 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete lymph node dissection
Number of subjects: 240
Study 27161539 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 240
Study 24850615 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-mediated cognitive behavioral (GMCB) intervention promoting home-based walking exercise.
Number of subjects: 0
Study 24850615 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving weekly on-site lectures unrelated to exercise.
Number of subjects: 0
Study 24850615 — intervention group
Group type: COMPARATOR
Intervention: Both groups (intervention and control) for WIQ distance score.
Number of subjects: 0
Study 22219220 — intervention group
Group type: EXPERIMENTAL
Intervention: Surinabant 2.5 mg/day
Number of subjects: 810
Study 22219220 — intervention group
Group type: EXPERIMENTAL
Intervention: Surinabant 5 mg/day
Number of subjects: 810
Study 22219220 — intervention group
Group type: EXPERIMENTAL
Intervention: Surinabant 10 mg/day
Number of subjects: 810
Study 22219220 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 810
Study 20524401 — intervention group
Group type: EXPERIMENTAL
Intervention: OXA + 5‐FU/LV
Number of subjects: 2107
Study 20524401 — intervention group
Group type: COMPARATOR
Intervention: IRI + 5‐FU/LV
Number of subjects: 2107
Study 18485010 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher number of cells (100,000,000) in Group H, n = 17
Number of subjects: 47
Study 18485010 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower number of cells (10,000,000) in Group L, n = 13
Number of subjects: 47
Study 18485010 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cell treatment) in Group C, n = 17
Number of subjects: 47
Study 15769986 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptives (30 mug ethinyl estradiol and 150 mug levonorgestrel) for 9 months
Number of subjects: 36
Study 15769986 — intervention group
Group type: COMPARATOR
Intervention: Control group (sedentary controls)
Number of subjects: 36
Study 15769986 — intervention group
Group type: COMPARATOR
Intervention: Regularly menstruating athletes
Number of subjects: 36
Study 15769986 — intervention group
Group type: COMPARATOR
Intervention: All groups (amenorrheic, regularly cycling, and sedentary controls)
Number of subjects: 36
Study 15769986 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 36
Study 11843507 — intervention group
Group type: EXPERIMENTAL
Intervention: Medtronic Freestyle root replacement
Number of subjects: 23
Study 11843507 — intervention group
Group type: COMPARATOR
Intervention: Homograft aortic root replacement
Number of subjects: 23
Study 11843507 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 23
Study 10406153 — intervention group
Group type: EXPERIMENTAL
Intervention: Defibrotide (800-1600 mg daily)
Number of subjects: 35
Study 10406153 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 35
Study 7500476 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic surgical arm
Number of subjects: 11
Study 7500476 — intervention group
Group type: COMPARATOR
Intervention: Human surgical assistant
Number of subjects: 11
Study 2210618 — intervention group
Group type: EXPERIMENTAL
Intervention: human growth hormone (hGH) alone
Number of subjects: 71
Study 2210618 — intervention group
Group type: EXPERIMENTAL
Intervention: combination therapy with oxandrolone
Number of subjects: 71
Study 2210618 — intervention group
Group type: COMPARATOR
Intervention: untreated control group
Number of subjects: 71
Study 2210618 — intervention group
Group type: EXPERIMENTAL
Intervention: subjects greater than or equal to 16 years of age
Number of subjects: 71
Study 6108555 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 200 mg i.v.
Number of subjects: 22
Study 6108555 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 50 mg i.v.
Number of subjects: 22
Study 31006614 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocaloric diet with a normocaloric hyperproteic formula (1035 kcal, 25% protein)
Number of subjects: 96
Study 31006614 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss greater than 15%
Number of subjects: 96
Study 30014665 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild moxibustion at Guanyuan (CV 4) and Sanyinjiao (SP 6), 20 minutes each time, once a day for 5 to 7 days before menstruation until menses, for 3 menstrual cycles.
Number of subjects: 30
Study 30014665 — intervention group
Group type: COMPARATOR
Intervention: Waiting list group (no intervention)
Number of subjects: 30
Study 30014665 — intervention group
Group type: COMPARATOR
Intervention: Healthy group (15 healthy individuals, no intervention)
Number of subjects: 30
Study 26966237 — intervention group
Group type: EXPERIMENTAL
Intervention: Chimney stove intervention installed at birth
Number of subjects: 443
Study 26966237 — intervention group
Group type: COMPARATOR
Intervention: Chimney stove intervention installed at 18 months
Number of subjects: 443
Study 24937643 — intervention group
Group type: EXPERIMENTAL
Intervention: Bosentan (n = 40)
Number of subjects: 60
Study 24937643 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 20)
Number of subjects: 60
Study 24937643 — intervention group
Group type: COMPARATOR
Intervention: Bosentan and Placebo
Number of subjects: 60
Study 22249235 — intervention group
Group type: EXPERIMENTAL
Intervention: Tube-shunt surgery
Number of subjects: 0
Study 22249235 — intervention group
Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin C (MMC)
Number of subjects: 0
Study 20638139 — intervention group
Group type: EXPERIMENTAL
Intervention: Lip strengthening exercises using an oral screen for 16 min, 5 days/week for 16 weeks.
Number of subjects: 8
Study 20638139 — intervention group
Group type: COMPARATOR
Intervention: Lip strengthening exercises using an oral screen.
Number of subjects: 8
Study 17204315 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with birch pollen extract
Number of subjects: 9
Study 17012870 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexavalent combined vaccine (DTaP‐IPV‐PRP approximately T‐HBs, HEXAVAC)
Number of subjects: 1028
Study 12182380 — intervention group
Group type: EXPERIMENTAL
Intervention: PncD (diphtheria toxoid)
Number of subjects: 160
Study 12182380 — intervention group
Group type: EXPERIMENTAL
Intervention: PncT (tetanus protein)
Number of subjects: 160
Study 12182380 — intervention group
Group type: EXPERIMENTAL
Intervention: PncD
Number of subjects: 160
Study 12182380 — intervention group
Group type: EXPERIMENTAL
Intervention: PncT
Number of subjects: 160
Study 12182380 — intervention group
Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 160
Study 10467325 — intervention group
Group type: EXPERIMENTAL
Intervention: CD34+ cell selected autologous PBSCT
Number of subjects: 30
Study 10467325 — intervention group
Group type: COMPARATOR
Intervention: Control group (unselected autologous PBSCT)
Number of subjects: 30
Study 8617415 — intervention group
Group type: EXPERIMENTAL
Intervention: Active medication
Number of subjects: 0
Study 8617415 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1965289 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentifrice containing 1.30% soluble pyrophosphate and 1.50% copolymer
Number of subjects: 0
Study 1965289 — intervention group
Group type: COMPARATOR
Intervention: Placebo dentifrice (no anticalculus ingredient)
Number of subjects: 0
Study 1965289 — intervention group
Group type: COMPARATOR
Intervention: Dentifrice containing 1.30% soluble pyrophosphate without copolymer
Number of subjects: 0
Study 6769032 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfinpyrazone
Number of subjects: 1558
Study 6769032 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1558
Study 29677190 — intervention group
Group type: EXPERIMENTAL
Intervention: Haplotype of rs9930506, rs9930501, and rs9932754 (GGT) in the FTO gene
Number of subjects: 237
Study 29677190 — intervention group
Group type: COMPARATOR
Intervention: GGC genotypes
Number of subjects: 237
Study 29677190 — intervention group
Group type: COMPARATOR
Intervention: AAT genotypes
Number of subjects: 237
Study 27712671 — intervention group
Group type: EXPERIMENTAL
Intervention: Needs-based exclusion
Number of subjects: 0
Study 27712671 — intervention group
Group type: COMPARATOR
Intervention: Statistical exclusion
Number of subjects: 0
Study 24765680 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostatic Urethral Lift (PUL)
Number of subjects: 0
Study 24765680 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 0
Study 22512984 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline assessment of visual acuity for fluid only
Number of subjects: 1185
Study 20541889 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-midvastus approach
Number of subjects: 27
Study 20541889 — intervention group
Group type: COMPARATOR
Intervention: Standard approach
Number of subjects: 27
Study 18447898 — intervention group
Group type: EXPERIMENTAL
Intervention: Static night splinting for six months worn at night time only, in addition to hand therapy.
Number of subjects: 102
Study 18447898 — intervention group
Group type: COMPARATOR
Intervention: Hand therapy only (non-splint group).
Number of subjects: 102
Study 15812372 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior MI patients
Number of subjects: 38
Study 15812372 — intervention group
Group type: COMPARATOR
Intervention: Control patients
Number of subjects: 38
Study 15812372 — intervention group
Group type: EXPERIMENTAL
Intervention: Inferior MI patients
Number of subjects: 38
Study 12593525 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclometasone dipropionate (BDP) 800 microg day(‐1) suspension for nebulization
Number of subjects: 0
Study 12593525 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (BUD) 750 microg day(‐1) given by nebulization
Number of subjects: 0
Study 10754623 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 180
Study 10754623 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 25 microg/kg
Number of subjects: 180
Study 10754623 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 50 microg/kg
Number of subjects: 180
Study 10754623 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 75 microg/kg
Number of subjects: 180
Study 10754623 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 100 microg/kg
Number of subjects: 180
Study 10754623 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 150 microg/kg
Number of subjects: 180
Study 8757525 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF
Number of subjects: 24
Study 8757525 — intervention group
Group type: EXPERIMENTAL
Intervention: GM-CSF
Number of subjects: 24
Study 8757525 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF and GM-CSF
Number of subjects: 24
Study 1287848 — intervention group
Group type: EXPERIMENTAL
Intervention: UFN (Unreamed Femoral Nailing)
Number of subjects: 16
Study 1287848 — intervention group
Group type: COMPARATOR
Intervention: AFN (Reamed Femoral Nailing)
Number of subjects: 16
Study 6389558 — intervention group
Group type: EXPERIMENTAL
Intervention: Above-elbow cast-brace with the forearm in supination
Number of subjects: 243
Study 6389558 — intervention group
Group type: EXPERIMENTAL
Intervention: Below-elbow cast-brace
Number of subjects: 243
Study 6389558 — intervention group
Group type: COMPARATOR
Intervention: Conventional Colles' type plaster
Number of subjects: 243
Study 31353989 — intervention group
Group type: EXPERIMENTAL
Intervention: nalbuphine 0.07 mg/kg
Number of subjects: 120
Study 31353989 — intervention group
Group type: EXPERIMENTAL
Intervention: dexmedetomidine 0.5 µg/kg
Number of subjects: 120
Study 31353989 — intervention group
Group type: COMPARATOR
Intervention: saline (control group)
Number of subjects: 120
Study 29079057 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold saline irrigation (20 mL at 2.5°C for 5 minutes)
Number of subjects: 210
Study 29079057 — intervention group
Group type: COMPARATOR
Intervention: Room temperature saline irrigation (control group)
Number of subjects: 210
Study 29231452 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture and moxibustion based on meridian differentiation
Number of subjects: 60
Study 29231452 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 60
Study 1444945 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA 5% Cream
Number of subjects: 60
Study 1444945 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylocaine 5%
Number of subjects: 60
Study 1444945 — intervention group
Group type: EXPERIMENTAL
Intervention: NUM (benzocaine 15%, amethocaine 1.7%)
Number of subjects: 60
Study 1444945 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 22876438 — intervention group
Group type: EXPERIMENTAL
Intervention: Weining granules
Number of subjects: 120
Study 22876438 — intervention group
Group type: COMPARATOR
Intervention: Weifuchun tablets
Number of subjects: 120
Study 20398351 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (1 gram by intravenous injection)
Number of subjects: 15000
Study 20398351 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sodium chloride 0.9%)
Number of subjects: 15000
Study 20398351 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 15000
Study 20398351 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15000
Study 18548827 — intervention group
Group type: COMPARATOR
Intervention: Mirtazapine 7.5, 15, 30, and/or 45 mg (Study 1)
Number of subjects: 85
Study 18548827 — intervention group
Group type: COMPARATOR
Intervention: Mirtazapine 15 mg (Study 2)
Number of subjects: 85
Study 18548827 — intervention group
Group type: COMPARATOR
Intervention: Mirtazapine (both studies)
Number of subjects: 85
Study 18548827 — intervention group
Group type: COMPARATOR
Intervention: Mirtazapine 15 mg + Compound CD0012 (Study 2)
Number of subjects: 85
Study 18548827 — intervention group
Group type: COMPARATOR
Intervention: Placebo (both studies)
Number of subjects: 85
Study 16217274 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic radiotherapy
Number of subjects: 0
Study 16217274 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 0
Study 16217274 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 0
Study 16217274 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatase inhibitors and 4-hydroxytamoxifen
Number of subjects: 0
Study 12455332 — intervention group
Group type: EXPERIMENTAL
Intervention: No time pressure (no response deadline)
Number of subjects: 399
Study 12455332 — intervention group
Group type: COMPARATOR
Intervention: Time pressure (response deadline of 5 s)
Number of subjects: 399
Study 10378706 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol (500 mg daily)
Number of subjects: 40
Study 10378706 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine (20 mg daily)
Number of subjects: 40
Study 8607678 — intervention group
Group type: EXPERIMENTAL
Intervention: Steel bands (4 to 6 bands)
Number of subjects: 48
Study 8607678 — intervention group
Group type: COMPARATOR
Intervention: Standard stainless steel wires (6 to 8 wires)
Number of subjects: 48
Study 1960301 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin (75 mg/day)
Number of subjects: 796
Study 6316518 — intervention group
Group type: EXPERIMENTAL
Intervention: Biostim (8 mg/day) for 15 days
Number of subjects: 10
Study 6316518 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 10
Study 30971316 — intervention group
Group type: EXPERIMENTAL
Intervention: F-100 intake
Number of subjects: 420
Study 30971316 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuberculosis infection
Number of subjects: 420
Study 30971316 — intervention group
Group type: EXPERIMENTAL
Intervention: Provision of special medication (IV fluid, IV antibiotic, and blood transfusion)
Number of subjects: 420
Study 30971316 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall recovery rate
Number of subjects: 420
Study 30971316 — intervention group
Group type: EXPERIMENTAL
Intervention: Mortality rate
Number of subjects: 420
Study 30971316 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean weight gain rate
Number of subjects: 420
Study 30971316 — intervention group
Group type: EXPERIMENTAL
Intervention: Incidence density rate of recovery
Number of subjects: 420
Study 30971316 — intervention group
Group type: EXPERIMENTAL
Intervention: Median time of recovery
Number of subjects: 420
Study 29436868 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen therapy (10 l/min)
Number of subjects: 160
Study 29436868 — intervention group
Group type: COMPARATOR
Intervention: Room air
Number of subjects: 160
Study 26471114 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency (150 Hz) insular stimulation for 10 min before pain testing
Number of subjects: 6
Study 24908627 — intervention group
Group type: EXPERIMENTAL
Intervention: Inadine dressing
Number of subjects: 0
Study 24908627 — intervention group
Group type: EXPERIMENTAL
Intervention: Acticoat dressing
Number of subjects: 0
Study 24908627 — intervention group
Group type: EXPERIMENTAL
Intervention: Activon Tulle dressing
Number of subjects: 0
Study 24908627 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 0
Study 24908627 — intervention group
Group type: COMPARATOR
Intervention: Saline soaked gauze control
Number of subjects: 0
Study 24908627 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma cytokines (IL‐4, TNFα, MCP‐1)
Number of subjects: 0
Study 24908627 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR array analysis
Number of subjects: 0
Study 22243494 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin + Anacetrapib
Number of subjects: 12
Study 19640014 — intervention group
Group type: EXPERIMENTAL
Intervention: Schema-Focused Therapy (SFT)
Number of subjects: 0
Study 19640014 — intervention group
Group type: COMPARATOR
Intervention: Transference-Focused Psychotherapy (TFP)
Number of subjects: 0
Study 22983102 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 0.25 mg/kg
Number of subjects: 50
Study 22983102 — intervention group
Group type: COMPARATOR
Intervention: Control (sodium chloride)
Number of subjects: 50
Study 15815895 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium infusion
Number of subjects: 37
Study 15815895 — intervention group
Group type: COMPARATOR
Intervention: Vecuronium infusion
Number of subjects: 37
Study 12444178 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV‐16 virus‐like‐particle vaccine (40 microg per dose)
Number of subjects: 2392
Study 12444178 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2392
Study 10349300 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg/day of ethylcysteine (EC) for 3 months
Number of subjects: 10
Study 10349300 — intervention group
Group type: COMPARATOR
Intervention: 600 mg/day of Vitamin E (Vit. E) for 3 months
Number of subjects: 10
Study 8953630 — intervention group
Group type: EXPERIMENTAL
Intervention: Timed 5 km cycle ergometer ride
Number of subjects: 52
Study 1941403 — intervention group
Group type: COMPARATOR
Intervention: Standard premature formula (1.34 microgram of Se/dl)
Number of subjects: 20
Study 1941403 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium-supplemented formula (2.03 micrograms of Se/dl)
Number of subjects: 20
Study 7173046 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine sulfate 60 mg po
Number of subjects: 22
Study 7173046 — intervention group
Group type: EXPERIMENTAL
Intervention: Codeine phosphate 60 mg im
Number of subjects: 22
Study 7173046 — intervention group
Group type: COMPARATOR
Intervention: Cigarette smoking
Number of subjects: 22
Study 29399865 — intervention group
Group type: EXPERIMENTAL
Intervention: 5000 IU cholecalciferol daily for 5 months
Number of subjects: 48
Study 29399865 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 48
Study 26879007 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch 6% 130/0.4 (Volulyte)
Number of subjects: 40
Study 26879007 — intervention group
Group type: COMPARATOR
Intervention: Gelatin (Geloplasma)
Number of subjects: 40